Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
Ketamine Analgesia Enhances Functional Quality and Mood in Chronic Pain Patients
1 other identifier
observational
500
1 country
1
Brief Summary
Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2018
CompletedFirst Submitted
Initial submission to the registry
August 2, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 27, 2025
January 1, 2025
7.9 years
August 2, 2023
January 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain score, objective measurement using the validated Numeric Pain Rating scale
Pain score, using the Numeric Pain Rating scale of 0 to 10, low scores indicate less pain, high scores indicate worse pain
12 weeks
Secondary Outcomes (1)
Sleep quality score, objective measurement using the validated Likert sleep scale
12 weeks
Eligibility Criteria
Adult chronic pain clinic patients who have mood disorders; and undergoing routine regular ketamine injections for pain therapy.
You may qualify if:
- adult chronic pain patients
- associated mood disorder
- good treatment compliance
- associated chronic insomnia
- regular ketamine pain therapy injection
- consent for clinical record quality assurance review
You may not qualify if:
- severe cognitive disorder
- inability to provide consent
- major neuropsychiatric disorder
- cannabis use
- stimulant use
- substance abuse
- poor treatment compliance
- lack of ketamine pain therapy injection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Salem Anaesthesia Pain Clinic
Surrey, British Columbia, V3S 7J1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olumuyiwa Bamgbade, MD,FRCPC
Salem Anaesthesia Pain Clinic
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2023
First Posted
August 14, 2023
Study Start
February 2, 2018
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 27, 2025
Record last verified: 2025-01